Amedeo Smart

Free Medical Literature Service


 

Amedeo

Kidney Transplantation

  Free Subscription

Articles published in
Br J Clin Pharmacol
    February 2026
  1. UMPIERREZ M, Maldonado C, Guevara N, Cardenas-Rodriguez M, et al
    Accelerating tacrolimus model-informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies.
    Br J Clin Pharmacol. 2026 Feb 11. doi: 10.1002/bcp.70447.
    >> Share

    January 2026
  2. YU H, Qin Z, Smith LS, Park JM, et al
    Mechanism-informed machine learning for individualized tacrolimus dose adjustment in the early post-kidney transplant period.
    Br J Clin Pharmacol. 2026 Jan 13. doi: 10.1002/bcp.70448.
    >> Share

  3. AHMER S, Bui J, Sivabalan P, Kotsiou G, et al
    Navigating therapeutic challenges: Voriconazole pharmacokinetics and CYP2C19 genetic polymorphism-A case report and literature review.
    Br J Clin Pharmacol. 2026;92:305-311.
    >> Share

    December 2025
  4. HOUWEN JPA, de Vries Schultink AHM, Peters BJM, Ruigrok D, et al
    Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series.
    Br J Clin Pharmacol. 2025;91:3542-3548.
    >> Share

    June 2025
  5. HAZENBROEK M, Pengel LHM, Sassen SDT, Massey EK, et al
    Removing the physician from the equation: Patient-controlled, home-based therapeutic drug self-monitoring of tacrolimus.
    Br J Clin Pharmacol. 2025;91:1560-1568.
    >> Share

    November 2024
  6. LEINO AD, Takyi-Williams J, Park JM, Norman SP, et al
    Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression.
    Br J Clin Pharmacol. 2024;90:2897-2909.
    >> Share

  7. SAQR A, Al-Kofahi M, Mohamed M, Dorr C, et al
    Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.
    Br J Clin Pharmacol. 2024;90:2837-2848.
    >> Share

    October 2024
  8. AGERGAARD K, Thiesson HC, Carstens J, Staatz CE, et al
    Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients.
    Br J Clin Pharmacol. 2024 Oct 10. doi: 10.1111/bcp.16277.
    >> Share

    June 2024
  9. VAN GELDER T, Gelinck A, Meziyerh S, de Vries APJ, et al
    Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve-based monitoring?
    Br J Clin Pharmacol. 2024 Jun 6. doi: 10.1111/bcp.16098.
    >> Share

    February 2024
  10. KHAMLEK K, Komenkul V, Sriboonruang T, Wattanavijitkul T, et al
    Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.
    Br J Clin Pharmacol. 2024;90:406-426.
    >> Share

    December 2023
  11. PASCHIER A, Destere A, Monchaud C, Labriffe M, et al
    Tacrolimus population pharmacokinetics in adult heart transplant patients.
    Br J Clin Pharmacol. 2023;89:3584-3595.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016